| BOTOX® Cosmetic U.S. FDA Approval -- One Year Later |
| Apr 30, 2003 - One year after the approval by the U.S. Food and Drug Administration (FDA), Allergan, Inc. (NYSE:AGN) today said BOTOX® Cosmetic (botulinum toxin type A) ranks as the most successful launch in the Company's 53-year history and the second most recognizable pharmaceutical brand in the United States. |
|
|
|
| HIGH-TECH, LIGHT-BASED HAIR REMOVAL IS EXCEPTIONALLY SAFE FOR ALL SKIN TYPES, CORNELL RESEARCHER REPORTS |
January 3, 2003 - New York, NY. High-tech hair removal using intense pulsed light (IPL) technology is exceptionally safe on all skin types, even among patients with dark or ethnic skin, according to a clinical study commissioned by Cornell University and published in the December 2002 issue of Cosmetic Dermatology. The study, conducted by Harvey Jay, M.D. of New York City, tracked the safety of IPL hair removal experiences in 250 consecutive new patients. All skin types were included in the study group with 77% having dark complexions. Researchers reported a less than 3% incidence of minor, temporary side effects, including pigment changes and acne-like rashes.
|
|
|
|
|
|
|
